tert-Butyl (4-cyanotetrahydro-2H-pyran-4-yl)carbamate

Catalog No. :
ACZCFR180
CAS No. :
519031-87-9
Molecular Formula :
C11H18N2O3
Molecular Weight :
226.28

IUPAC Name:tert-butyl (4-cyanotetrahydro-2H-pyran-4-yl)carbamate

tert-Butyl (4-cyanotetrahydro-2H-pyran-4-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$307.00Login to see priceInquiryInquiry
250mg95%$512.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (4-cyanotetrahydro-2H-pyran-4-yl)carbamate
IUPAC Nametert-butyl (4-cyanotetrahydro-2H-pyran-4-yl)carbamate
MDL No.MFCD25964086
Molecular FormulaC11H18N2O3
Molecular Weight226.28
SMILESO=C(OC(C)(C)C)NC1(C#N)CCOCC1
InChI KeyGFMHNORFBIULNJ-UHFFFAOYSA-N
Synonymtert-butyl 4-cyano-tetrahydro-2H-pyran-4-ylcarbamate;tert-Butyl N-(4-cyanooxan-4-yl)carbamate;Carbamic acid, N-(4-cyanotetrahydro-2H-pyran-4-yl)-, 1,1-dimethylethyl ester
CAS No.519031-87-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZCFR180 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3 In Stock
  2. Plus
  3. ACYSHJ149 route compound structure diagram
    ACYSHJ149848821-06-7 In Stock
  4. Then
  5. ACZCFR180 route product structure diagram
    ACZCFR180519031-87-9
Inquiry

2. ACZCFR180 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZCFR180 route product structure diagram
    ACZCFR180519031-87-9
Inquiry

Comments (0)